Lecornet E, Ahmed HU, Hu Y, Moore CM, Nevoux P, Barratt D et al. The accuracy of different biopsy strategies for the detection of clinically important prostate cancer: a computer simulation. J Urol 2012; 188: 974–980.
Kvale R, Moller B, Wahlqvist R, Fossa SD, Berner A, Busch C et al. Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study. BJU Int 2009; 103: 1647–1654.
Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 2015; 313: 390–397.
Moore CM, Robertson NL, Arsanious N, Middleton T, Villers A, Klotz L et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 2013; 63: 125–140.
Kuru TH, Roethke MC, Seidenader J, Simpfendorfer T, Boxler S, Alammar K et al. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol 2013; 190: 1380–1386.
Bjurlin MA, Mendhiratta N, Wysock JS, Taneja SS. Multiparametric MRI and targeted prostate biopsy: improvements in cancer detection, localization, and risk assessment. Central Eur J Urol 2016; 69: 9–18.
Harris RD, Schned AR, Heaney JA. Staging of prostate cancer with endorectal MR imaging: lessons from a learning curve. Radiographics 1995; 15: 813–829 discussion 829–832.
Rosenkrantz AB, Ayoola A, Hoffman D, Khasgiwala A, Prabhu V, Smereka P et al. The learning curve in prostate MRI interpretation: self-directed learning versus continual reader feedback. AJR Am J Roentgenol 2017; 208: W92–w100.
Rosenkrantz AB, Pujara AC, Taneja SS. Use of a quality improvement initiative to achieve consistent reporting of level of suspicion for tumor on multiparametric prostate MRI. AJR Am J Roentgenol 2016; 206: 1040–1044.
Emberton M. Has magnetic resonance-guided biopsy of the prostate become the standard of care? Eur Urol 2013; 64: 720–721.
Greer MD, Choyke PL, Turkbey B. PI-RADSv2: How we do it. J Magn Reson Imaging 2017; 46: 11–23.
Yerram NK, Volkin D, Turkbey B, Nix J, Hoang AN, Vourganti S et al. Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int 2012; 110: E783–E788.
Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G et al. ESUR prostate MR guidelines 2012. Eur Radiol 2012; 22: 746–757.
Naing NN. Easy way to learn standardization: direct and indirect methods. Malays J Med Sci 2000; 7: 10–15.
Ramsay CR, Grant AM, Wallace SA, Garthwaite PH, Monk AF, Russell IT. Assessment of the learning curve in health technologies. A systematic review. Int J Technol Assess Health Care 2000; 16: 1095–1108.
Subramonian K, Muir G. The 'learning curve' in surgery: what is it, how do we measure it and can we influence it? BJU Int 2004; 93: 1173–1174.
Gold RH, Bassett LW, Widoff BE. Highlights from the history of mammography. Radiographics 1990; 10: 1111–1131.
Miglioretti DL, Gard CC, Carney PA, Onega TL, Buist DS, Sickles EA et al. When radiologists perform best: the learning curve in screening mammogram interpretation. Radiology 2009; 253: 632–640.
Volkin D, Turkbey B, Hoang AN, Rais-Bahrami S, Yerram N, Walton-Diaz A et al. Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers. BJU Int 2014; 114: E43–E49.
Kongnyuy M, Sidana A, George AK, Muthigi A, Iyer A, Fascelli M et al. The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men. Urol Oncol 2016; 34: e215–e221.
Gaziev G, Wadhwa K, Barrett T, Koo BC, Gallagher FA, Serrao E et al. Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI-transrectal ultrasonography (TRUS) fusion-guided transperineal prostate biopsies as a validation tool. BJU Int 2016; 117: 80–86.
Buus S, Rylander S, Hokland S, Sondergaard CS, Pedersen EM, Tanderup K et al. Learning curve of MRI-based planning for high-dose-rate brachytherapy for prostate cancer. Brachytherapy 2016; 15: 426–434.
Ou YC, Yang CK, Chang KS, Wang J, Hung SW, Tung MC et al. The surgical learning curve for robotic-assisted laparoscopic radical prostatectomy: experience of a single surgeon with 500 cases in Taiwan, China. Asian J Androl 2014; 16: 728–734.
Atug F, Castle EP, Srivastav SK, Burgess SV, Thomas R, Davis R. Positive surgical margins in robotic-assisted radical prostatectomy: impact of learning curve on oncologic outcomes. Eur Urol 2006; 49: 866–871 discussion 871-862.
Ahlering TE, Eichel L, Edwards RA, Lee DI, Skarecky DW. Robotic radical prostatectomy: a technique to reduce pT2 positive margins. Urology 2004; 64: 1224–1228.
Zorn KC, Wille MA, Thong AE, Katz MH, Shikanov SA, Razmaria A et al. Continued improvement of perioperative, pathological and continence outcomes during 700 robot-assisted radical prostatectomies. Can J Urol 2009; 16: 4742–4749.
Patel VR, Palmer KJ, Coughlin G, Samavedi S. Robot-assisted laparoscopic radical prostatectomy: perioperative outcomes of 1500 cases. J Endourol 2008; 22: 2299–2305.
Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst 2007; 99: 1171–1177.
Latchamsetty KC, Borden LS Jr, Porter CR, Lacrampe M, Vaughan M, Lin E et al. Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve? Can J Urol 2007; 14: 3429–3434.
Akin O, Riedl CC, Ishill NM, Moskowitz CS, Zhang J, Hricak H. Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer. Eur Radiol 2010; 20: 995–1002.
Fleshner K, Carlsson SV, Roobol MJ. The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA. Nat Rev Urol 2017; 14: 26–37.
McGinley KF, McMahon GC, Brown GA. Impact of the US Preventive Services Task Force Grade D Recommendation: Assessment of Evaluations for elevated prostate-specific antigen and prostate biopsies in a large urology group practice following statement revision. Rev Urol 2015; 17: 171–177.
Banerji JS, Wolff EM, Massman JD 3rd, Odem-Davis K, Porter CR, Corman JM. Prostate needle biopsy outcomes in the era of the U.S. Preventive Services Task Force Recommendation against prostate specific antigen based screening. J Urol 2016; 195: 66–73.
Olsson C, Anderson A, Kapoor D. MP39-04 initial prostate cancer detection before and after United States Preventive Services Task Force Recommendation on prostate cancer screening. J Urol 195: e542.
Rosenberg M, Crawford D, Newmark J, Steiner M. MP39-01 use of PSA screening guidelines among primary care physicians. J Urol 195: e541.